Vorrat
30 Days
Format
Flüssig liposomal
Portion
10 ml täglich
Human RCT Proven
Made in Germany
EFSA Bone Claim
LSO-MG
5.18× OBV vs. standard tablet · liposomal magnesium bisglycinate
LipoSone™ Liposomal Magnesium — 5.18 times higher bioavailability than standard non-liposomal tablet magnesium in a human RCT (n=20). Sustained elevated plasma magnesium levels for the full 12-hour study window. Magnesium contributes to the maintenance of normal bones. Made in Germany.
oder €35.70/Monat mit Abonnieren & Sparen 15%
Melden Sie sich für unseren Newsletter an, um bei Wiederverfügbarkeit benachrichtigt zu werden.
Kostenloser EU-Versand · 30-Tage-Garantie · Sicherer Checkout
Human RCT Proven
Made in Germany
EFSA Bone Claim
GMP Certified
Your 90-Day Protocol
Day 1
Commit to the protocol: same time, same dose, every day. Consistency is the active ingredient no formula can substitute.
Week 1
Seven days in. The most important work happening now is behavioural — you're cementing the routine that makes supplementation work.
Day 14
Most nutritional actives are studied across 4–12 week windows. At two weeks your protocol is running — not complete.
Day 30
A full month of consistent intake. If you've been tracking anything — energy, sleep, mood — now is a useful moment to note what, if anything, has shifted. Individual results vary.
Day 60–90
At 60–90 days you're running the timeline most nutritional supplement research is built around. This is where meaningful individual differences emerge.
* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary.
Fragen
Wissenschaft
Vier präzisionssequenzierte biologische Ereignisse, die diese Formulierung von herkömmlichen Nahrungsergänzungsmitteln unterscheiden.
Schritt 01
Magnesium bisglycinate encased in phospholipid liposomes, protecting it through digestion
Schritt 02
Liposomal delivery bypasses degradation pathways that limit standard tablet uptake
Schritt 03
Plasma magnesium stayed above the 0.85–1.10 nmol/L reference range for the full study window
Schritt 04
Magnesium contributes to the maintenance of normal bones
Formel
Klinische Dosierungen. Keine proprietären Mischungen. Vollständige Transparenz bei jedem Wirkstoff.
| Wirkstoff | Herkunft | Klinische Dosis | Hauptfunktion | Verabreichung |
|---|---|---|---|---|
Magnesium (as bisglycinate, liposomal) Magnesium Bisglycinate [] | 100mg/10mL | Contributes to the maintenance of normal bones | 5.18× OBV vs. standard non-liposomal tablet (RCT n=20) |
Transparenz
Verifizierte Lieferkettendokumentation — kein Marketingtext.
Evidenz
EFSA-registrierte gesundheitsbezogene Angaben und peer-reviewte Begleitliteratur. Jede [n] auf dieser Seite verlinkt hierher.
“”
EFSA Journal 2009;7(9):1216, doi:10.2903/j.efsa.2009.1216
